Compliance updated on Jun 19, 2026 Screened by AAOIFI-Certified Shariah Advisor & Auditor

Financial data updated nightly

Dexcom Inc

DXCM ✓ COMPLIANT ☆ Track — members

Nasdaq · Healthcare · Medical Equipment, Supplies & Distribution ·

USA Large Cap Analyst: BUY

Last Close

$89.75

▼ -1.89%

Market Cap $33.87B · Vol 1.51M

Key Metrics

P/E Ratio

35.61

FWD: 30.44

Market Cap

$33.87B

Large Cap

Div Yield

N/A

EPS Growth

+27.60%

YoY

RSI (14)

76.99

Momentum

Beta

1.42

vs Market

52W High

$91.93

2.37% below

52W Low

$54.12

65.84% above

Volume

1.51M

Avg 1.94M

P/B

9.30

Price-to-book

ROE

34.16%

Return on equity

Free Float

99.62%

Public shares

Shariah Compliance8 STANDARDS

✓ Yes, Dexcom Inc (DXCM) stock is Shariah compliant

AAOIFI—
Dow Jones Islamic (DJIM)—
FTSE Shariah—
MSCI Islamic—
S&P Shariah—
Al Rajhi—
Alinma—
Albilad—

Unlock the full Shariah report

See the verdict under each standard, the exact screening ratios, purification and zakat per share. AAOIFI-certified methodology trusted by global Islamic funds.

Which standards does DXCM pass?

The full report shows the verdict under each of the 8 major Shariah standards, with the business-activity and financial-ratio screens behind every one.

Do I need to purify my investment?

Members see the purification amount per share, updated every financial period under the AAOIFI methodology.

Can I calculate zakat for my shares?

Members get zakat per share and a built-in calculator for their exact holding.

Historical Returns

+5.90%

+21.09%

+55.22%

+28.18%

YTD

+35.23%

+12.24%

-21.62%

-26.94%

Financials & Valuation

TTM · Annual

Total Revenue	$4.66B
Net Income	$836.30M
Revenue Growth (YoY)	+13.08%
Gross Margin	62.09%
Operating Margin	21.70%
Net Profit Margin	17.94%
ROE	34.16%
ROA · ROIC	16.97% · 19.66%

P/E Ratio	35.61
Forward P/E (FY1)	30.44
PEG Ratio	0.67
P/S	5.77
P/B	9.30
P/FCF	24.98
EPS Growth	+27.60%
Outstanding Shares	377.36M

Technical Indicators

50-Day SMA	$76.11
200-Day SMA	$68.69
RSI (14)	76.99
Beta	1.42
52-Week High	$91.93
52-Week Low	$54.12

Volume Today	1.51M
Avg Daily Volume (30D)	1.94M
Relative Volume	0.78x
Volatility (10D)	41.01
Volatility (30D)	50.25
Free Float	99.62%

Analyst Consensus

BUY

Current Price $89.75

Mean Target $93.88

52W Low$54.12 52W High$91.93

Current

Target

$54.12 $91.93

Current Analyst target

+4.60% upside potential · 30 analysts

Identifiers

ExchangeNasdaq

FIGIBBG001SKZG99

ISINUS2521311074

CountryUnited States of America

Sub-IndustryMedical Equipment, Supplies & Distribution (NEC)

Earnings DateOct 28, 2026

TypeStocks

Instrument TypeORD Ordinary Share

Similar Halal Stocks

ABT Abbott Laboratories -0.02% MDT Medtronic PLC +0.76% COR Cencora Inc +1.23% 7741.T Hoya Corp +0.32% BDX Becton Dickinson and Co +0.79%

Company Profile

DexCom, Inc. is a medical device company. The Company is primarily focused on the design, development, and commercialization of continuous glucose monitoring (CGM), systems for the management of diabetes and metabolic health by patients, caregivers, and clinicians. It enables people to take control of health through innovative biosensing technology. The G7 is an integrated continuous glucose monitoring system. Stelo is designed specifically for people with type II diabetes who do not use insulin as the first over-the-counter glucose biosensor in the United States. The Dexcom Share remote monitoring system, offered for use with any Dexcom system, uses an app on the patient’s compatible mobile device. Its Dexcom G7 is for adults and children (2+ years) living with type I or type II diabetes who are on any insulin or medications, at risk of hypoglycemia, and those with gestational diabetes. The G7 and G7 15 Day includes finger stick elimination, continuous glucose readings and others.